Africa's pharma supply chains are stronger than they were a decade ago. Still, infra gaps, fragmented regulations and cross-border bottlenecks continue to challenge the timely movement of medicines.

Novartis claims life sciences lie at the centre of a shift in geopolitics and policies in regions like Europe, Japan, and Canada are "self-defeating."

Artificial intelligence (AI) is becoming embedded into the fabric of quality, compliance, and production systems.

Tariffs on US pharma imports could remove discounts offered to health systems by biosimilars and threaten the future of the sector, says a non-profit.

FTSE 100 giants GSK and AstraZeneca appear to be exempt from higher-rate Trump tariffs according to the City.

The boss’s bonus is an annual debating point at Britain’s biggest company. But that’s not the only issue this year